Poster Session: Clinical Trials
Joachim Doua, MD, MPH
Janssen Research & Development, Infectious Diseases & Vaccines, Janssen Pharmaceutica
Beerse, Antwerpen, Belgium
Miquel Ekkelenkamp, MD, PhD
Department of Medical Microbiology, University Medical Center Utrecht
Utrecht, Utrecht, Netherlands
Stephen Ruhmel, MPH
Janssen Research & Development
Titusville, New Jersey, United States
Kimberly Leathers, Clinical Research Associate
Duke University
Durham, North Carolina, United States
Oscar Go, PhD
Associate Director
Janssen Research & Development
Raritan, New Jersey, United States
Ranee Chatterjee, MD, MPH
Duke University
South Durham, North Carolina, United States
Michal Sarnecki, MD
Medical Leader VX Bern Clin
Janssen Research & Development, Janssen Vaccines
Bern, Bern, Switzerland
Jan Poolman, PhD
VP Bacterial Vaccines
Bacterial Vaccines Discovery and Early Development, Janssen Vaccines & Prevention B.V.
Leiden, Zuid-Holland, Netherlands
Marc Bonten, MD, PhD
Julius Center for Health Sciences and Primary Care, University Medical Center
Utrecht, Utrecht, Netherlands